TriggerFinger


Hydroxychloroquin improves odds of hospitalization by 84%


Wasington ExaminerA peer-reviewed study measuring the effectiveness of a controversial drug cocktail that includes hydroxychloroquine concluded that the treatment lowered hospitalizations and mortality rates of coronavirus patients.

The study, set to be published in the International Journal of Antimicrobial Agents in December, determined that “Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”

A total of 141 patients diagnosed with the coronavirus were treated with the three-drug cocktail over a period of five days and compared to a control group of 377 people who tested positive for the virus but were not given the treatment.

The study found that “the odds of hospitalisation of treated patients was 84% less than in the untreated patients,” and only one patient died from the group being treated with the drugs compared to 13 deaths in the untreated group.

They did the treatment regimen correctly, and it worked. The results appear better than the high tech new therapeutics (which improved odds by about 25%, IIRC).

This entry was published Thu Dec 03 08:44:36 CST 2020 by TriggerFinger and last updated 2020-12-03 08:44:36.0. [Tweet]

comments powered by Disqus

Related Categories


Subscribe to Atom Feed

I am not a lawyer, and nothing on this site should be taken as legal advice.

This site is run on custom blog software and is being actively developed. Please be forgiving of errors.


This website is an Amazon affiliate and will receive financial compensation for products purchased from Amazon through links on this site.